A detailed history of Gratus Capital LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Gratus Capital LLC holds 760,289 shares of TEVA stock, worth $16.8 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
760,289
Previous 770,133 1.28%
Holding current value
$16.8 Million
Previous $10.9 Million 13.69%
% of portfolio
0.52%
Previous 0.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$12.78 - $17.4 $125,806 - $171,285
-9,844 Reduced 1.28%
760,289 $12.4 Million
Q1 2024

May 13, 2024

BUY
$10.67 - $14.43 $19,686 - $26,623
1,845 Added 0.24%
770,133 $10.9 Million
Q4 2023

Feb 07, 2024

BUY
$8.12 - $10.63 $39,974 - $52,331
4,923 Added 0.64%
768,288 $8.02 Million
Q3 2023

Oct 26, 2023

BUY
$7.48 - $10.7 $5.71 Million - $8.17 Million
763,365 New
763,365 $7.79 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.